What Schedule Is GUAIFENESIN AND DEXTROMETHORPHAN HBR?
GUAIFENESIN AND DEXTROMETHORPHAN HBR scheduling and classification across Australia, United States, and international jurisdictions. Also known as Guaifenesin and Dextromethorphan HBr.
GUAIFENESIN AND DEXTROMETHORPHAN HBR (Guaifenesin and Dextromethorphan HBr) is classified as S2 (Pharmacy Medicine - available from a pharmacy without a prescription, but must be provided by a pharmacist) under the Therapeutic Goods Administration (TGA) in Australia. It is FDA approved in the United States.
Key Takeaways
- Australia (TGA): S2 - Pharmacy Medicine - available from a pharmacy without a prescription, but must be provided by a pharmacist
- United States (FDA): Approved (Rx only)
- Risk level: Low (1 points)
Scheduling by Jurisdiction
| Jurisdiction | Regulatory Body | Classification | Status |
|---|---|---|---|
| Australia | TGA (Therapeutic Goods Administration) | S2 | Not PBS listed |
| United States | FDA / DEA | Rx only (not DEA scheduled) | FDA approved |
What S2 Means for GUAIFENESIN AND DEXTROMETHORPHAN HBR
GUAIFENESIN AND DEXTROMETHORPHAN HBR is classified as S2 under the TGA Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP). Pharmacy Medicine - available from a pharmacy without a prescription, but must be provided by a pharmacist.
Claims and Workers Compensation Implications
When GUAIFENESIN AND DEXTROMETHORPHAN HBR (S2) appears on a claimant's medication list, the scheduling classification affects how claims professionals should assess and manage the claim.
Need to assess this medication across your caseload?
Check GUAIFENESIN AND DEXTROMETHORPHAN HBR scheduling, interactions, and compliance across your claimant's full medication list.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
No credit card required. No signup for your first 2 questions.
Related Resources
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.